Krystal Biotech Announces Publication of Phase 1 and 2 Clinical Trial (GEM 1/2 Study) of Beremagene Geperpavec (B-VEC) Data in Nature Medicine
Source:
Nasdaq GlobeNewswire
/
28 Mar 2022 11:00:00 America/New_York
N/A
Share on,